Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
Public ClinicalTrials.gov record NCT06020014. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AZD4604 Twice Daily for Twelve Weeks in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2a, multicentre, randomised, placebo-controlled, double-blind, parallel-group study to evaluate the efficacy, safety and PK of AZD4604 administered BID using a dry-powder inhaler at one dose level over a 12-week Treatment period in adult participants with uncontrolled moderate-to-severe asthma.
Study identification
- NCT ID
- NCT06020014
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 339 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 16, 2023 (Actual)
- Primary completion
- Oct 28, 2025 (Actual)
- Completion
- Oct 28, 2025 (Actual)
- Last update posted
- Nov 13, 2025
2023 – 2025
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35209 | — |
| Research Site | Chandler | Arizona | 85224 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | Sacramento | California | 95817 | — |
| Research Site | Lakeland | Florida | 33813 | — |
| Research Site | Miami | Florida | 33126 | — |
| Research Site | Atlanta | Georgia | 30344 | — |
| Research Site | Hammond | Indiana | 46324 | — |
| Research Site | New Bedford | Massachusetts | 02740 | — |
| Research Site | Ann Arbor | Michigan | 48109 | — |
| Research Site | Southfield | Michigan | 48075 | — |
| Research Site | Saint Charles | Missouri | 63301 | — |
| Research Site | Las Vegas | Nevada | 89106 | — |
| Research Site | Union City | New Jersey | 07087 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Research Site | New Bern | North Carolina | 28562 | — |
| Research Site | Salisbury | North Carolina | 28144 | — |
| Research Site | Winston-Salem | North Carolina | 27104 | — |
| Research Site | Columbus | Ohio | 43207 | — |
| Research Site | Boerne | Texas | 78006 | — |
| Research Site | El Paso | Texas | 79902 | — |
| Research Site | Houston | Texas | 77074 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06020014, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 13, 2025 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06020014 live on ClinicalTrials.gov.